These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7888107)

  • 41. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 42. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
    Le Bars PL
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Piracetam treatment in ischemic stroke].
    Tomczykiewicz K; Domzał T
    Neurol Neurochir Pol; 1997; 31(6):1101-9. PubMed ID: 9591298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease.
    Burns A; Perry E; Holmes C; Francis P; Morris J; Howes MJ; Chazot P; Lees G; Ballard C
    Dement Geriatr Cogn Disord; 2011; 31(2):158-64. PubMed ID: 21335973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of piracetam in children with learning disorders.
    Simeon J; Waters B; Resnick M
    Psychopharmacol Bull; 1980 Jul; 16(3):65-6. PubMed ID: 7403408
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial.
    Wilkinson D; Windfeld K; Colding-Jørgensen E
    Lancet Neurol; 2014 Nov; 13(11):1092-1099. PubMed ID: 25297016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (Cognex) in Alzheimer's patients.
    Smith F
    J Biopharm Stat; 1996 Mar; 6(1):59-67. PubMed ID: 8838779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A controlled clinical trial on the effect of piracetam in epileptic children.
    Kunneke PS; Malan GM
    Br J Clin Pract; 1979 Sep; 33(9):266-71. PubMed ID: 385029
    [No Abstract]   [Full Text] [Related]  

  • 51. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of Piracetam on dyslexic's reading ability.
    Wilsher C; Atkins G; Manfield P
    J Learn Disabil; 1985 Jan; 18(1):19-25. PubMed ID: 3881545
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
    Seltzer B
    J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 56. Drugs to treat Alzheimer's disease.
    J Psychosoc Nurs Ment Health Serv; 2013 Apr; 51(4):11-2. PubMed ID: 23565878
    [No Abstract]   [Full Text] [Related]  

  • 57. NICE approves drugs for Alzheimer's disease.
    Kmietowicz Z
    BMJ; 2001 Jan; 322(7280):190. PubMed ID: 11159606
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of piracetam on volunteers in a low-pressure tank.
    Demay F; Bande J
    J Int Med Res; 1980; 8(1):90-4. PubMed ID: 7358211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany.
    Guo S; Hernandez L; Wasiak R; Gaudig M
    J Med Econ; 2010; 13(4):641-54. PubMed ID: 20958114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.